Rhodes John B 4
4 · Tonix Pharmaceuticals Holding Corp. · Filed Mar 9, 2018
Insider Transaction Report
Form 4
Rhodes John B
Director
Transactions
- Exercise/Conversion
Restricted Stock Units
2017-02-09−1,125→ 0 total→ Common Stock (750 underlying) - Exercise/Conversion
Common Stock, $0.001 par value
2017-05-27+1,125→ 15,970 total - Exercise/Conversion
Common Stock, $0.001 par value
2016-02-25+600→ 8,720 total - Exercise/Conversion
Restricted Stock Units
2016-02-25−600→ 0 total→ Common Stock (600 underlying) - Exercise/Conversion
Common Stock, $0.001 par value
2017-02-09+1,125→ 14,845 total - Exercise/Conversion
Restricted Stock Units
2017-05-27−1,125→ 0 total→ Common Stock (750 underlying)
Footnotes (4)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]On May 27, 2016, the reporting person was granted 750 restricted stock units, vesting in on the first anniversary of the grant date.
- [F3]On February 9, 2016, the reporting person was granted 750 restricted stock units, vesting in on the first anniversary of the grant date.
- [F4]On February 25, 2015, the reporting person was granted 600 restricted stock units, vesting in on the first anniversary of the grant date.